Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 04:00PM ET
205.70
Dollar change
+2.70
Percentage change
1.33
%
Index- P/E88.76 EPS (ttm)2.32 Insider Own3.90% Shs Outstand38.68M Perf Week-2.07%
Market Cap7.96B Forward P/E53.59 EPS next Y3.84 Insider Trans-0.74% Shs Float37.20M Perf Month-8.47%
Income90.95M PEG- EPS next Q0.38 Inst Own89.21% Short Float5.18% Perf Quarter-18.69%
Sales1.06B P/S7.52 EPS this Y34.83% Inst Trans1.14% Short Ratio5.68 Perf Half Y0.10%
Book/sh30.48 P/B6.75 EPS next Y36.22% ROA6.21% Short Interest1.93M Perf Year-26.51%
Cash/sh7.47 P/C27.53 EPS next 5Y- ROE8.35% 52W Range180.93 - 348.67 Perf YTD-18.22%
Dividend Est.- P/FCF96.94 EPS past 5Y66.20% ROI6.50% 52W High-41.00% Beta0.55
Dividend TTM- Quick Ratio3.49 Sales past 5Y19.41% Gross Margin63.55% 52W Low13.69% ATR (14)6.78
Dividend Ex-Date- Current Ratio6.06 EPS Y/Y TTM4515.14% Oper. Margin8.67% RSI (14)36.51 Volatility2.48% 2.92%
Employees4200 Debt/Eq0.20 Sales Y/Y TTM24.95% Profit Margin8.59% Recom1.56 Target Price278.08
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q1284.05% Payout0.00% Rel Volume1.15 Prev Close203.00
Sales Surprise-0.68% EPS Surprise8.76% Sales Q/Q28.69% EarningsMay 07 AMC Avg Volume339.69K Price205.70
SMA20-4.64% SMA50-12.16% SMA200-15.90% Trades Volume391,951 Change1.33%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Downgrade JP Morgan Overweight → Neutral $284 → $250
Sep-06-23Initiated Morgan Stanley Equal-Weight $265
Jul-19-23Initiated Robert W. Baird Outperform $375
Mar-29-23Downgrade Needham Buy → Hold
Jan-30-23Initiated Piper Sandler Overweight $275
Nov-04-22Upgrade Citigroup Neutral → Buy $217 → $212
Oct-12-22Initiated Jefferies Buy $230
Oct-05-22Downgrade Citigroup Buy → Neutral $170 → $217
Sep-09-22Upgrade Needham Hold → Buy
Jul-18-22Initiated RBC Capital Mkts Outperform $195
Apr-23-24 09:45AM
09:00AM
Apr-09-24 04:05PM
Apr-08-24 09:35AM
Apr-04-24 01:55AM
09:49AM Loading…
Mar-05-24 09:49AM
Feb-27-24 09:45AM
Feb-26-24 11:42AM
Feb-23-24 11:40AM
10:44AM
12:11AM
Feb-22-24 05:40PM
04:35PM
04:35PM
04:05PM
07:12AM Loading…
Feb-20-24 07:12AM
Feb-18-24 01:26PM
Feb-15-24 10:00AM
Feb-01-24 04:05PM
Jan-18-24 11:39AM
Dec-22-23 09:37AM
Dec-21-23 07:01AM
Dec-19-23 10:30AM
Dec-18-23 07:50PM
Nov-30-23 09:55AM
07:37AM
Nov-28-23 09:54AM
09:00AM
Nov-17-23 01:03PM
Nov-14-23 04:05PM
10:19AM Loading…
10:19AM
Nov-10-23 05:43PM
Nov-03-23 08:59AM
08:29AM
08:18AM
Nov-02-23 06:09PM
05:20PM
04:05PM
Nov-01-23 04:05PM
Oct-27-23 04:44AM
Oct-24-23 11:42AM
Oct-12-23 11:03AM
Oct-11-23 11:38AM
Oct-05-23 04:05PM
Oct-04-23 11:02PM
09:50AM
Sep-27-23 09:55AM
Sep-22-23 08:09AM
05:20AM
Sep-21-23 09:40AM
Sep-20-23 01:45PM
Sep-19-23 06:20AM
Sep-14-23 07:38PM
01:09PM
Sep-11-23 07:55AM
Sep-06-23 11:42AM
09:36AM
Sep-05-23 09:40AM
Sep-01-23 09:55AM
Aug-31-23 11:31AM
Aug-30-23 08:15AM
Aug-23-23 04:05PM
05:58AM
Aug-22-23 10:28AM
Aug-18-23 12:41PM
12:35PM
Aug-17-23 11:21AM
11:12AM
09:09AM
09:00AM
Aug-16-23 10:21AM
Aug-14-23 01:22PM
11:31AM
Aug-11-23 10:34AM
Aug-10-23 11:48AM
11:37AM
Aug-09-23 10:31AM
Aug-08-23 12:48PM
11:21AM
Aug-07-23 12:12PM
Aug-04-23 12:30PM
12:08PM
10:07AM
07:22AM
Aug-02-23 02:20PM
11:51AM
07:26AM
Aug-01-23 05:25PM
04:19PM
04:05PM
Jul-26-23 04:05PM
Jul-25-23 04:46AM
Jul-12-23 07:43AM
Jul-11-23 06:05PM
Jul-08-23 10:21AM
Jul-05-23 04:05PM
Jun-27-23 04:41AM
Jun-26-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:51AM
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts JohannaEVP, Gen. Counsel & SecretaryApr 01 '24Sale217.07600130,24264,281Apr 03 07:42 PM
Kassing Don W.DirectorApr 01 '24Sale223.1817037,9411,175Apr 03 07:42 PM
Elsesser AdamCEO and PresidentMar 06 '24Option Exercise7.755,00038,7505,000Mar 08 08:10 PM
Bose AraniDirectorMar 04 '24Sale250.207,5001,876,500164,294Mar 05 07:44 PM
Kassing Don W.DirectorMar 01 '24Sale234.72778182,6121,345Mar 05 07:46 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryMar 01 '24Sale237.68600142,60762,997Mar 05 07:45 PM
Grewal HarpreetDirectorJan 03 '24Sale240.8217040,9398,980Jan 04 07:34 PM
Sarna SurbhiDirectorJan 02 '24Sale247.688521,0532,295Jan 04 07:36 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryDec 27 '23Option Exercise22.042,45053,99863,597Dec 29 07:31 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryDec 01 '23Sale226.42600135,85162,251Dec 05 07:55 PM
O'Rourke BridgetDirectorNov 30 '23Sale226.4115033,9624,214Dec 04 07:41 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryNov 14 '23Sale214.14600128,48263,037Nov 16 07:35 PM
Elsesser AdamCEO and PresidentOct 11 '23Option Exercise7.759,67074,9429,670Oct 13 07:33 PM
Elsesser AdamCEO and PresidentOct 11 '23Sale215.769,6702,086,4170Oct 13 07:33 PM
Shiu LambertChief Accounting OfficerOct 09 '23Option Exercise12.362,75033,99019,466Oct 11 07:31 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryOct 02 '23Sale237.82600142,69163,637Oct 04 07:30 PM
Grewal HarpreetDirectorOct 02 '23Sale240.9917040,9689,150Oct 04 07:44 PM
Sarna SurbhiDirectorOct 02 '23Sale240.998520,4842,380Oct 04 07:34 PM
Elsesser AdamCEO and PresidentSep 11 '23Option Exercise7.759,66674,9129,666Sep 13 07:48 PM
Elsesser AdamCEO and PresidentSep 11 '23Sale298.769,6662,887,8210Sep 13 07:48 PM
Kassing Don W.DirectorSep 08 '23Sale288.66444128,1651,458Sep 12 08:03 PM
Roberts JohannaEVP, Gen. Counsel & SecretarySep 01 '23Sale265.11600159,06764,237Sep 06 08:03 PM
Grewal HarpreetDirectorSep 01 '23Sale266.6234090,6519,320Sep 06 08:02 PM
O'Rourke BridgetDirectorSep 01 '23Sale266.6210026,6624,364Sep 06 07:59 PM
Sarna SurbhiDirectorSep 01 '23Sale266.628522,6632,465Sep 06 08:01 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryAug 14 '23Sale249.85600149,91064,837Aug 16 08:07 PM
Elsesser AdamCEO and PresidentAug 11 '23Option Exercise7.759,66674,9129,666Aug 14 08:57 PM
Elsesser AdamCEO and PresidentAug 11 '23Sale247.219,6662,389,5730Aug 14 08:57 PM
Kassing Don W.DirectorAug 08 '23Sale251.0032381,0731,902Aug 09 08:09 PM
Wilder ThomasDirectorAug 07 '23Sale253.4834086,183340Aug 09 08:11 PM
Elsesser AdamCEO and PresidentJul 11 '23Option Exercise7.759,66674,9129,666Jul 13 09:08 PM
Elsesser AdamCEO and PresidentJul 11 '23Sale322.989,6663,121,9560Jul 13 09:08 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryJul 03 '23Sale340.18900306,16265,437Jul 06 08:22 PM
Sarna SurbhiDirectorJul 03 '23Sale341.45279,2192,550Jul 06 08:23 PM
Elsesser AdamCEO and PresidentJun 12 '23Option Exercise7.759,66674,9129,666Jun 14 08:43 PM
Elsesser AdamCEO and PresidentJun 12 '23Sale324.499,6663,136,4810Jun 14 08:43 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryJun 01 '23Sale309.30900278,36866,337Jun 05 07:28 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryMay 12 '23Option Exercise22.0465214,37070,425May 16 07:32 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryMay 12 '23Sale319.671,500479,50568,925May 16 07:32 PM
Elsesser AdamCEO and PresidentMay 11 '23Option Exercise7.759,66674,9129,666May 15 07:31 PM
Elsesser AdamCEO and PresidentMay 11 '23Sale318.529,6663,078,8620May 15 07:31 PM
Bose AraniDirectorMay 01 '23Sale285.875,0001,429,328182,629May 03 07:50 PM